Use of systemic glucocorticosteroids in pregnancy: Be alert but not alarmed

Australasian Journal of Dermatology

Volumn 47, Issue 1, 2006, Pages 34-36

  Rennick, Gordon J ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b SKIN AND CANCER FOUNDATION   (Australia)

Author keywords

Brain; Central nervous system; Foetus; Newborn; Prenatal exposure delayed effect

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; PREDNISOLONE;

BRAIN DEVELOPMENT; BRAIN GROWTH; CEREBROVASCULAR ACCIDENT; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FETUS DEVELOPMENT; FETUS LUNG MATURITY; HUMAN; HYPERTENSION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERINATAL DRUG EXPOSURE; PREGNANCY; PREMATURE LABOR; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL DEVELOPMENT; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK ASSESSMENT; SKIN DISEASES;

EID: 33645003131     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2006.00219.x     Document Type: Review

References (28)

1. Medicines in Pregnancy Working Party of the Australian Drug Evaluation Committee. Prescribing Medicines in Pregnancy - An Australian Categorisation of Risk of Drug Use in Pregnancy 4th edn Canberra Therapeutic Goods Administration, Department of Health and Ageing 1999. Available from URL: (Accessed 13 Aug 2005).
2. Liggins GC Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants Pediatrics 1972 50 515 25
3. Cochrane AL. Effectiveness and EfficiencyRandom Reflections on Health Services London Nuffield Provincial Hospitals Trust 1972
4. Cochrane AL. 1931-1971: A critical review, with particular reference to the medical profession. In: Teeling-Smith G Wells N (eds) Medicines for the Year 2000 London Office of Health Economics 1979; 1 11
5. Crowley P Chalmers I Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials BrJObstetGynaecol 1990 97 11 25
6. Crowley P. Prophylactic corticosteroids for preterm birth Cochrane Database SystRev 1996, Issue 1. Art. No.: CD000065. DOI.: 10.1002/14651858. CD000065.
7. Cochrane collaboration logo at (Accessed 7 Aug. 2005).
8. Quinlivan JA Evans SF Dunlop SA Beazley LD Newnham JP. Use of corticosteroids by Australian obstetricians - a survey of clinical practice AustNZJObstetGynaecol 1998 38 1 7
9. Planer BC Ballard RA Ballard PL Coburn C Boardman C Cnaan A Morgan M Parer J. Use of antenatal corticosteroids in USA AmJObstetGynecol 1996 174 467 (Abstract 576).
10. Brocklehurst P Gates S McKenzie-McHarg K Alfirevic Z Chamberlain G. Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK BrJObstetGynaecol 1999 106 977 9
11. Whitelaw A Thoresen M. Antenatal steroids and the developing brain ArchDisChildFetalNeonatal Ed 2000 83 F154 7
12. Jobe AH. Animal models of antenatal corticosteroids: clinical implications ClinObstetGynecol 2003 46 174 89
13. Huang WL Beazley LD Quinlivan JA Evans SF Newnham JP Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep ObstetGynecol 1999 94 213 18
14. Uno H Lohmiller L Thieme C Kemnitz JW Engle MJ Roecker EB Farrell PM. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus Brain ResDevBrain Res 1990 53 157 67
15. Quinlivan JA Beazley LD Evans SF Newnham JP Dunlop SA. Retinal maturation is delayed by repeated, but not single, maternal injections of betamethasone in sheep Eye 2000 14 93 8
16. French NP Hagan R. Evans SF Godfrey M Newnham JP. Repeated antenatal corticosteroids; size at birth and subsequent development AmJObstetGynecol 1999 180 114 21
17. Shelton SD Boggess KA Murtha AP Groff AO Herbert WN. Repeated fetal betamethasone treatment and birth weight and head circumference ObstetGynecol 2001 97 301 4
18. Abassi S Hirsch D Davis J Tolosa J Stouffer N Debbs R. Gerdes JS. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome AmJObstetGynecol 2000 182 1243 9
19. O'Shea TM Doyle LW. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective SeminNeonatol 2001 6 293 307
20. Seckl JR Cleasby M Nyirenda MJ. Glucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programming Kidney Int 2000 57 1412 17
21. Edwards LJ Coulter CL Symonds M McMillen IC. Prenatal undernutrition, glucocorticoids and the programming of adult hypertension ClinExpPharmacolPhysiol 2001 28 938 41
22. Newnham JP. Is prenatal glucocorticoid administration another origin of adult disease? ClinExpPharmacolPhysiol 2001 28 957 61
23. Doyle LW Ford GW Davis NM Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children ClinSci 2000 98 137 42
24. Crowther CA Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease Cochrane Database SystRev 2003, Issue 2. Art. No.: CD003935.
25. Padbury JF Ervin MG Polk DH. Extrapulmonary effects of antenatally administered steroids JPediatr 1996 128 167 72
26. Beitins IZ Bayard F Ances IG Kowarski A Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term JPediatr 1972 81 936 45
27. Moore LE Martin JN. When betamethasone and dexamethasone are unavailable: hydrocortisone JPerinatol 2001 21 456 8
28. Warner M Camisa C. Topical corticosteroids. In: Wolverton SE (ed.). Comprehensive Dermatologic Drug Therapy Philadelphia, PA WB Saunders 2001 548 77